ATOSSA THERAPEUTICS, INC. ATOS Cash Flow

Atossa therapeutics, inc. (ATOS)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
-16,113	-17,239	-16,699	-16,723	-13,603	-11,404	-11,319	-10,194	-8,293	-8,122	-8,653	-6,264	-5,744	-6,368	-8,806	-13,329	-14,752	-15,760	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Adjustments to reconcile net loss to net cash used in operating activities
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,657	-11,602	-11,859	-11,254	-10,784	0	0	0	-	-	-	-
Net loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,002	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Bad debt expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Compensation cost for stock options granted
7,514	7,102	6,673	6,253	1,114	1,053	952	844	846	786	786	819	838	876	856	878	883	840	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Disposal of assets
-	-	-	-	-	-	-	-	-	-17	17	-17	-17	-163	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Common shares issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	155	0	0	0	0
Change in stock-based compensation liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	556	801	829	1,399	1,443	1,213	1,062	351	121	0	0	0
Loss on reduction on obsolete inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	29	0	0	0
Loan initiation fee accrued for notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Depreciation and amortization
51	52	55	53	50	44	55	73	96	128	178	224	267	303	331	369	284	272	267	282	419	480	503	499	499	472	455	340	220	130	0	0	0
Change in fair value of stock-based compensation liability
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Bad debt expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-63	-52	214	352	352	342	302	140	0	0	0
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9	41	50	91	9	0	0	0	-	-	-	-	29	0	0	0
Prepaid expenses
501	352	139	372	339	258	132	212	200	79	36	19	66	-21	-0	-22	0	-0	-145	-93	-213	-1	200	151	212	57	11	-21	168	91	0	0	0
Research and development tax rebate receivable
496	221	88	-219	-158	159	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
106	-4	-217	-48	-25	-74	0	0	0	-	-	-60	-60	-144	-24	-4	-128	110	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Security deposits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-41	-43	3	-29	0	0	0
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Accounts payable
-107	-60	-49	127	295	18	170	-304	-218	80	183	213	-42	-560	-723	-297	-537	301	481	-209	675	264	169	500	17	-58	-40	-20	-62	3	0	0	0
Decrease (Increase) in accrued payroll
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2	5	-10	-27	-45	-52	-51	35	48	0	0	0	-	-	-	-
Product recall liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-211	0	0	0	-	-	-	-	-	-	-	-
Accrued expenses
-22	-99	173	-233	-97	86	1	242	138	73	38	-31	-134	-446	759	284	30	209	-952	-248	1	41	-405	-924	-1,060	-704	-596	566	1,443	1,198	0	0	0
Payroll liabilities
-425	-35	63	-363	535	150	78	470	25	14	-7	-10	-394	-389	-387	-235	-691	199	235	115	986	379	0	0	0	-	-	-	-	-	-	-	-
Product recall liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Other current liabilities
-6	-27	-47	-3	-13	24	52	4	0	9	-5	-3	18	-58	4	3	-39	21	-107	-95	-77	-91	-39	-59	33	-8	0	0	0	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9,264	-11,808	-11,319	-10,897	-10,312	-8,363	-8,461	-10,484	-10,244	-10,099	-8,830	0	0	0	-	-	-	-
Net cash used in discontinued operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,633	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-10,209	-9,128	-8,863	-9,392	-8,723	-8,961	-8,200	-7,604	-7,119	-6,593	0	0	0	-	-	-	-	-13,953	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment
-	-	-	-	-	110	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of furniture, fixtures and equipment
-	-	-	-	-	-	-	-	-	-	4	4	4	9	84	193	107	130	-210	-237	-133	-158	0	183	247	244	450	185	104	104	0	0	0
Purchases of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	163	375	407	336	245	84	38	38	30	0	0	0
Net cash used in continuing investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-130	215	229	70	-4	-376	-591	-584	-489	0	0	0	-	-	-	-
Net cash used in discontinued investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-157	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-110	0	0	0	-	-4	-4	-4	-9	-182	-211	-227	-288	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from exercise of warrants
0	11,336	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	4,695	4,654	2,087	7,331	9,456	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock and warrants, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25,889	13,936	16,005	8,102	4,857	3,854	0	0	0
Repayments from bank line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,000	0	0	0
Repayments of loans from related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-5	0	0	0
Cash released from commercial line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	0	0	0
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,087	7,331	9,456	9,350	9,554	4,393	13,057	14,541	22,694	25,889	13,936	0	0	0	-	-	-	-
Net cash provided by financing activities
-	11,336	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
-10,217	2,200	2,408	1,876	14,843	3,218	10,201	11,546	3,612	4,189	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
SUPPLEMENTAL DISCLOSURES
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
-	-	-	-	-	-	-	-	-	-	-	-	-	-687	-3,451	-10,212	-6,845	-4,784	-3,534	-2,895	-6,862	2,158	3,680	11,858	15,205	4,616	7,274	2,351	485	-185	0	0	0
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	16	16	16	15	2	2	-1	0	1	9	15	14	0	0	0
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation
-	3,151	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of commitment shares
-	-	-	-	-	72	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of commitment shares issued for shares distributed for capital contribution
-	-	-	-	-	-	-	-	-	-	75	75	62	42	-10	-30	3	355	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Common stock and warrants issued for asset purchase
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,674	4,674	0	0	0
Noncash reclassification of prepaid license fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	-	-	-
Options issued for previously accrued director compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	45	0	0	0
Commitment shares distributed for capital contribution
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,387	0	0	0	0
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	79	0	0	0	0